Dramatic improvement of severe acne pustolosa after adalimumab in a patient with ulcerative colitis.
Ontology highlight
ABSTRACT: A 22-year-old male with extensive steroid-dependent/azathioprine-refractory ulcerative colitis and preexistent severe refractory acne pustolosa (AP) was successfully treated with adalimumab for both conditions. Severe AP could be considered a further indication, instead of a relative restriction, to anti-TNFα in steroid-dependent IBD patients needing therapy with this class of drugs.
SUBMITTER: Rispo A
PROVIDER: S-EPMC4831381 | biostudies-other | 2016 Apr
REPOSITORIES: biostudies-other
ACCESS DATA